Consultation: Reporting requirements for safety issues - Proposed changes to the 'Pharmacovigilance responsibilities of medicine sponsors: Australian recommendations and requirements'

This activity is now closed…

Unfortunately, this activity is now closed and no more online responses will be accepted.

Return to overview page